MGO One Seven’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $513K | Buy |
968
+64
| +7% | +$29.5K | 0.01% | 964 |
|
|
2026
Q1 | $434K | Buy |
904
+175
| +24% | +$89.6K | 0.01% | 963 |
|
|
2025
Q4 | $409K | Sell |
729
-8
| -1% | -$4.54K | 0.01% | 973 |
|
|
2025
Q3 | $379K | Buy |
737
+54
| +8% | +$23.6K | 0.01% | 923 |
|
|
2025
Q2 | $214K | Sell |
683
-33
| -5% | -$9.91K | 0.01% | 1114 |
|
|
2025
Q1 | $218K | Sell |
716
-273
| -28% | -$91.8K | 0.01% | 988 |
|
|
2024
Q4 | $329K | Buy |
989
+203
| +26% | +$68.8K | 0.01% | 803 |
|
|
2024
Q3 | $262K | Sell |
786
-379
| -33% | -$144K | 0.01% | 823 |
|
|
2024
Q2 | $480K | Sell |
1,165
-273
| -19% | -$108K | 0.02% | 577 |
|
|
2024
Q1 | $581K | Sell |
1,438
-369
| -20% | -$130K | 0.03% | 480 |
|
|
2023
Q4 | $554K | Sell |
1,807
-134
| -7% | -$36.2K | 0.03% | 492 |
|
|
2023
Q3 | $470K | Buy |
1,941
+10
| +0.5% | +$2.56K | 0.04% | 459 |
|
|
2023
Q2 | $464K | Buy |
1,931
+295
| +18% | +$61.3K | 0.04% | 435 |
|
|
2023
Q1 | $308K | Sell |
1,636
-5
| -0.3% | -$1.03K | 0.02% | 666 |
|
|
2022
Q4 | $349K | Sell |
1,641
-23
| -1% | -$4.59K | 0.03% | 505 |
|
|
2022
Q3 | $261K | Buy |
1,664
+10
| +0.6% | +$1.6K | 0.01% | 581 |
|
|
2022
Q2 | $248K | Sell |
1,654
-56
| -3% | -$8.11K | 0.03% | 521 |
|
|
2022
Q1 | $280K | Sell |
1,710
-66
| -4% | -$10.9K | 0.03% | 524 |
|
|
2021
Q4 | $387K | Buy |
1,776
+27
| +2% | +$5.65K | 0.04% | 428 |
|
|
2021
Q3 | $396K | Sell |
1,749
-1,357
| -44% | -$248K | 0.05% | 383 |
|
|
2021
Q2 | $549K | Sell |
3,106
-1,036
| -25% | -$179K | 0.08% | 309 |
|
|
2021
Q1 | $679K | Buy |
4,142
+1,421
| +52% | +$217K | 0.12% | 220 |
|
|
2020
Q4 | $379K | Buy |
+2,721
| New | +$343K | 0.08% | 321 |
|
|
2020
Q3 | – | Sell |
-2,771
| Closed | -$258K | – | 482 |
|
|
2020
Q2 | $258K | Sell |
2,771
-100
| -3% | -$8.51K | 0.07% | 359 |
|
|
2020
Q1 | $210K | Sell |
2,871
-88
| -3% | -$7.64K | 0.07% | 347 |
|
|
2019
Q4 | $248K | Sell |
2,959
-97
| -3% | -$7.51K | 0.06% | 362 |
|
|
2019
Q3 | $257K | Buy |
+3,056
| New | +$231K | 0.07% | 342 |
|
|
2019
Q2 | – | Sell |
-4,918
| Closed | -$290K | – | 429 |
|
|
2019
Q1 | $290K | Buy |
4,918
+2,444
| +99% | +$146K | 0.09% | 286 |
|
|
2018
Q4 | $130K | Buy |
+2,474
| New | +$136K | 0.06% | 385 |
|
|
2018
Q1 | $191K | Sell |
5,471
-338
| -6% | -$12.3K | 0.09% | 276 |
|
|
2017
Q4 | $211K | Buy |
+5,809
| New | +$204K | 0.1% | 242 |
|
Other funds holding MEDP
WA
MGO One Seven's MEDP Position: Q2 2026 in Review
MGO One Seven increased its Medpace (MEDP) stake by 7.1% in Q2 2026, buying an estimated $29.5K and bringing the position to 968 shares worth $513K. The position accounts for 0.01% of the portfolio, ranked #964.
MGO One Seven first reported a position in MEDP in Q4 2017 and has held it in 31 quarters since. The position peaked at $679K in Q1 2021. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- MGO One Seven held 968 shares of Medpace worth $513K as of Q2 2026.
- MGO One Seven bought 64 Medpace shares in Q2 2026, an estimated $29.5K.
- Medpace made up 0.01% of MGO One Seven's portfolio in Q2 2026, its #964 holding.
- MGO One Seven first reported a position in Medpace in Q4 2017 and has held it in 31 quarters since.
- MGO One Seven's Medpace position peaked at $679K in Q1 2021.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.